AZN Stock Summary and Trading Ideas (Astrazeneca PLC - American Depositary Shares | NASDAQ:AZN)

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.

Astrazeneca PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AZN.

As of February 3, 2023, AZN stock price climbed to $63.44 with 4,173,942 million shares trading.

AZN has a beta of 0.46, meaning it tends to be less sensitive to market movements. AZN has a correlation of 0.15 to the broad based SPY ETF.

AZN has a market cap of $196.55 billion. This is considered a Large Cap stock.

Last quarter Astrazeneca PLC - American Depositary Shares reported $11 billion in Revenue and $.84 earnings per share. This beat revenue expectation by $72 million and exceeded earnings estimates by $.12.

In the last 3 years, AZN stock traded as high as $72.12 and as low as $36.15.

The top ETF exchange traded funds that AZN belongs to (by Net Assets): QQQ, FVD, NUGO, QYLD, QQQM.

AZN has outperformed the market in the last year with a return of +13.1%, while the SPY ETF lost -6.3%. However, in the most recent history, AZN shares have underperformed the stock market with its stock returning +5.9% in the last 3 month period and -8.3% for the last 2 week period, while SPY has returned +11.6% and +4.2%, respectively.

AZN support price is $62.23 and resistance is $64.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AZN stock will trade within this expected range on the day.